R. Parra

发表

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on‐demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

M. Álvarez‐Román, R. Villarrubia, I. Oyagüez, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Analysis of INF-γ, TNF-α and Dendritic Cells to Predict Hepatitis C Virus Recurrence in Liver Transplant Patients

S. Sauleda, I. Bilbao, C. Margarit, 2005 .

Diagnosis and management of von willebrand disease in Spain

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018 .

FK506 in the maturation of dendritic cells.

I. Bilbao, C. Margarit, R. Parra, 2002, Haematologica.

Prophylaxis therapy in haemophilia A: current situation in Spain

V. Jiménez‐Yuste, J. Batlle, R. Parra, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

The optimal mode of delivery for the haemophilia carrier expecting an affected infant: further considerations

C. Altisent, R. Parra, F. Vidal, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, PloS one.

Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes

C. Altisent, R. Parra, C. Torrents, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Focusing on haemophilia B: prophylaxis in Spanish patients

V. Jiménez‐Yuste, J. Batlle, R. Parra, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia in Spain

V. Jiménez‐Yuste, J. Batlle, R. Parra, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Is on‐demand treatment effective in patients with severe haemophilia?

V. Jiménez‐Yuste, R. Parra, J. Aznar, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD‐US) score

V. Jiménez‐Yuste, C. Altisent, M. Álvarez‐Román, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three‐year follow‐up of the AHEAD (Advate in HaEmophilia A outcome Database) study

G. Spotts, J. Oldenburg, C. Hermans, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Recovery of recombinant factor IX determined in clinical practice

C. Altisent, R. Parra, M. Martorell, 2009, Haemophilia.

Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2015, Thrombosis and Haemostasis.

Real World Prospective Data on Bleeding Frequency in 1,000 Patients with Hemophilia a - is the Goal of Zero Bleeds Achievable?

J. Oldenburg, K. Khair, K. Kurnik, 2017 .

Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic‐guided prophylaxis based on Bayesian models with myPKFiT®

M. Mingot-Castellano, R. Parra, R. Núñez, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Liver transplantation in Spanish haemophiliacs

V. Jiménez‐Yuste, R. Parra, J. Aznar, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10‐year follow‐up study

M. Vilardell‐Tarrés, C. Altisent, R. Parra, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnostic delay in acquired haemophilia: Analysis of causes and consequences in a 20‐year Spanish cohort

C. Altisent, R. Parra, J. Pardos-Gea, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Common Genetic Variants in ABO and CLEC4M Modulate the Pharmacokinetics of Recombinant FVIII in Severe Hemophilia A Patients

C. Altisent, M. Álvarez‐Román, R. Parra, 2020, Thrombosis and Haemostasis.

Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series

A. Iorio, T. Lambert, M. Makris, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

Striving for a Bleed Free World - An Interim Analysis from the AHEAD Study

J. Oldenburg, K. Khair, K. Kurnik, 2016 .

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis

M. Díaz-Ricart, G. Escolar, C. Altisent, 2020, Platelets.

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2017, Haematologica.

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2020, Thrombosis and Haemostasis.

High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods

C. Altisent, R. Parra, D. Arteta, 2012, Haematologica.

Molecular characterization of ten F8 splicing mutations in RNA isolated from patient's leucocytes: assessment of in silico prediction tools accuracy

J. Barquinero, R. Parra, F. Vidal, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients’ platelets and leukocytes

C. Altisent, R. Parra, F. Vidal, 2011, Journal of thrombosis and haemostasis : JTH.

Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene

C. Altisent, R. Parra, F. Vidal, 2009, Thrombosis and Haemostasis.

A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.

K. Shianna, D. Goldstein, J. Goedert, 2013, Human molecular genetics.

Cutaneous infiltration by histiocytic lymphoma in a patient with acute monocytic leukemia (M5a)

R. Parra, A. Casanovas, J. Maciá, 1994, European journal of haematology.

Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Prognostic value of tumor necrosis factor in plasma of patients with chronic lymphoproliferative syndromes: preliminary results.

R. Parra, A. Esquerda, J. Maciá, 1994, Blood.

Severe hypercalcemia indicating relapse of acute myelocytic leukemia after bone marrow transplantation.

J. Montoliu, R. Parra, J. Maciá, 1992, Nephron.

Archeogenetics of F11 p.Cys38Arg: a 5400-year-old mutation identified in different southwestern European countries.

J. Corral, V. Vicente, F. Bauduer, 2019, Blood.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, Haematologica.

Variable readthrough responsiveness of nonsense mutations in hemophilia A

J. Barquinero, R. Parra, F. Vidal, 2019, Haematologica.

Advanced cell‐based modeling of the royal disease: characterization of the mutated F9 mRNA

J. Barquinero, C. Altisent, R. Parra, 2017, Journal of Thrombosis and Haemostasis.

The ‘royal disease’ mutation in a Spanish patient

C. Altisent, R. Parra, F. Vidal, 2010, Journal of thrombosis and haemostasis : JTH.

Integration of molecular and clinical data of 40 unrelated von Willebrand Disease families in a Spanish locus-specific mutation database: first release including 58 mutations

C. Altisent, R. Parra, F. Vidal, 2010, Haematologica.